Knockdown of METTL14 suppresses the malignant progression of non‑small cell lung cancer by reducing Twist expression
Cited by 24
Related Papers
Discovery of <i>N</i>-((3<i>R</i>,4<i>R</i>)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-9-methyl-9<i>H</i>-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
|Journal of Medicinal Chemistry|2017|90
Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes
|Frontiers in Immunology|2023|77
Development of FAP-Targeted Chimeric Antigen Receptor NK-92 Cells for Non-Small Cell Lung Cancer
|Discovery Medicine|2023|25